Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

With an antibody whose duty's double, a step towards ending asthma trouble?

Sundberg EJ.

Biochem J. 2013 Apr 15;451(2):e1-3. doi: 10.1042/BJ20130305.

PMID:
23535171
2.

Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1.

Redpath NT, Xu Y, Wilson NJ, Fabri LJ, Baca M, Andrews AE, Braley H, Lu P, Ireland C, Ernst RE, Woods A, Forrest G, An Z, Zaller DM, Strohl WR, Luo CS, Czabotar PE, Garrett TP, Hilton DJ, Nash AD, Zhang JG, Nicola NA.

Biochem J. 2013 Apr 15;451(2):165-75. doi: 10.1042/BJ20121819.

PMID:
23384096
3.

In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.

Berry LM, Adams R, Airey M, Bracher MG, Bourne T, Carrington B, Cross AS, Davies GC, Finney HM, Foulkes R, Gozzard N, Griffin RA, Hailu H, Lamour SD, Lawson AD, Lightwood DJ, McKnight AJ, O'Dowd VL, Oxbrow AK, Popplewell AG, Shaw S, Stephens PE, Sweeney B, Tomlinson KL, Uhe C, Palframan RT.

Int Immunopharmacol. 2009 Feb;9(2):201-6. doi: 10.1016/j.intimp.2008.11.001. Epub 2008 Nov 27.

PMID:
19041426
4.

Structure of IL-17A in complex with a potent, fully human neutralizing antibody.

Gerhardt S, Abbott WM, Hargreaves D, Pauptit RA, Davies RA, Needham MR, Langham C, Barker W, Aziz A, Snow MJ, Dawson S, Welsh F, Wilkinson T, Vaugan T, Beste G, Bishop S, Popovic B, Rees G, Sleeman M, Tuske SJ, Coales SJ, Hamuro Y, Russell C.

J Mol Biol. 2009 Dec 18;394(5):905-21. doi: 10.1016/j.jmb.2009.10.008. Epub 2009 Oct 14.

PMID:
19835883
5.

New insights into the role of cytokines in asthma.

Renauld JC.

J Clin Pathol. 2001 Aug;54(8):577-89. Review.

6.

New approaches in the treatment of asthma.

Ramshaw HS, Woodcock JM, Bagley CJ, McClure BJ, Hercus TR, Lopez AF.

Immunol Cell Biol. 2001 Apr;79(2):154-9. Review.

7.

[Inflammatory cytokines (IL-4, IL-5 and IL-13)].

Maeda S, Yanagihara Y.

Nihon Rinsho. 2001 Oct;59(10):1894-9. Review. Japanese.

PMID:
11676128
8.

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.

Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, Corbett CR, Andonov A.

MAbs. 2010 Jan-Feb;2(1):53-66. Epub 2010 Jan 27.

9.

Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.

Krause S, Behrends J, Borowski A, Lohrmann J, Lang S, Myrtek D, Lorenzen T, Virchow JC, Luttmann W, Friedrich K.

Mol Immunol. 2006 Apr;43(11):1799-807. Epub 2005 Dec 20.

PMID:
16364441
10.

Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.

Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, Thornber M, Puddicombe SM, Buchanan D, Wilson SJ, Djukanović R, Holgate ST, Davies DE.

J Immunol. 2002 Jul 1;169(1):407-14.

11.

Genetic variants of IL-13 signalling and human asthma and atopy.

Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, Umeshita R, Abe Y, Braun S, Yamashita T, Roberts MH, Sugimoto R, Arima K, Arinobu Y, Yu B, Kruse S, Enomoto T, Dake Y, Kawai M, Shimazu S, Sasaki S, Adra CN, Kitaichi M, Inoue H, Yamauchi K, Tomichi N, Kurimoto F, Hamasaki N, Hopkin JM, Izuhara K, Shirakawa T, Deichmann KA.

Hum Mol Genet. 2000 Mar 1;9(4):549-59.

12.

Agents against cytokine synthesis or receptors.

Yamagata T, Ichinose M.

Eur J Pharmacol. 2006 Mar 8;533(1-3):289-301. Epub 2006 Feb 2. Review.

PMID:
16457805
13.

Identification of potent antagonist antibodies against mouse IL-13Rα1 using novel bioassays.

Edwards KM, Huynh H, Prasad R, McDonald A, Hardy MP, Scotney P, Owczarek CM, Busfield SJ, Panousis C, Wilson NJ.

J Immunol Methods. 2014 May;407:48-57. doi: 10.1016/j.jim.2014.03.019. Epub 2014 Apr 3.

PMID:
24704819
14.

Structure, binding, and antagonists in the IL-4/IL-13 receptor system.

Mueller TD, Zhang JL, Sebald W, Duschl A.

Biochim Biophys Acta. 2002 Nov 11;1592(3):237-50. Review.

15.

Airway hyperresponsiveness: a story of mice and men and cytokines.

Townley RG, Horiba M.

Clin Rev Allergy Immunol. 2003 Feb;24(1):85-110. Review.

PMID:
12644720
16.

Signal transduction of IL-13 and its role in the pathogenesis of bronchial asthma.

Izuhara K, Arima K.

Drug News Perspect. 2004 Mar;17(2):91-8. Review.

PMID:
15098062
17.

One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.

Blech M, Peter D, Fischer P, Bauer MM, Hafner M, Zeeb M, Nar H.

J Mol Biol. 2013 Jan 9;425(1):94-111. doi: 10.1016/j.jmb.2012.09.021. Epub 2012 Oct 3.

PMID:
23041424
18.

Regulatory role of antigen-induced interleukin-10, produced by CD4(+) T cells, in airway neutrophilia in a murine model for asthma.

Nabe T, Ikedo A, Hosokawa F, Kishima M, Fujii M, Mizutani N, Yoshino S, Ishihara K, Akiba S, Chaplin DD.

Eur J Pharmacol. 2012 Feb 29;677(1-3):154-62. doi: 10.1016/j.ejphar.2011.12.020. Epub 2011 Dec 23.

PMID:
22209878
19.

MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM, Reed JL, Woods R, Dall'acqua WW, Stephens GL, Erjefalt JS, Bjermer L, Humbles AA, Gossage D, Wu H, Kiener PA, Spitalny GL, Mackay CR, Molfino NA, Coyle AJ.

J Allergy Clin Immunol. 2010 Jun;125(6):1344-1353.e2. doi: 10.1016/j.jaci.2010.04.004.

PMID:
20513525
20.

[Interleukin 10 in disseminated lupus erythematosus].

Emilie D.

J Soc Biol. 2002;196(1):19-21. Review. French.

PMID:
12134628
Items per page

Supplemental Content

Write to the Help Desk